MRM Proteomics Inc. and Biodesix® have inked a partnership to create novel assays to answer critical clinical questions within the lung cancer continu.

Lung cancer diagnostic developer Biodesix is partnering up with MRM Proteomics to license its iMALDI automated assay technology for quantifying proteins using mass spectrometry, with the goal of en ...

This Analysis reports the development and assessment of 645 multiple reaction monitoring (MRM) mass spectrometry assays to quantify 319 targeted human breast cancer proteins. The results of this ...

The Centre of Excellence for the Prevention of Organ Failure (PROOF Centre) and MRM Proteomics are collaborating to bring new diagnostic blood tests which will help clinicians manage patients with ...

Agilent Technologies Inc. and MRM Proteomics Inc. announce the launch of MRM Proteomics' PeptiQuant MRM Assay Kits for quality control in quantitative plasma proteomic analyses based on ...

PURPOSE: This study provides population-based estimates of the treatment costs for elderly women with early-stage breast cancer, with emphasis on costs of modified radical mastectomy (MRM) compared ...